跳至主要内容
临床试验/DRKS00032767
DRKS00032767招募中Unknown

Deep-phenotyping and personalized therapy of patients with irritable bowel syndrome - PIONEER-IBS

niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik0 个研究点目标入组 75 人开始时间: 2023年10月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • * Irritable bowel syndrome according to ROM-IV criteria,
  • * Irritable bowel syndrome in clinical assessment,
  • * Patients who agree to participate in the study for at least 5 months,
  • * Written informed consent

排除标准

  • * Severe psychopathology preventing group therapy (e.g. acute schizophrenic disorder, acute suicidality, current substance dependence (alcohol/drugs)).
  • * Psychopathology preventing short-term EMDR treatment (e.g. severe dissociative symptoms (DES-II >25%), complex post-traumatic stress disorder).
  • * Severe comorbid organic disorder preventing participation (e.g. palliative terminal cancer, serious nephrological, hepatic, cardiovascular or neurological disease).
  • *Pregnancy

研究者

发起方
niversitätsklinikum Heidelberg, Abteilung für Allgemeine Innere Medizin und Psychosomatik

相似试验